The importance of regorafenib and lenvatinib in the treatment of hepatocellular carcinoma.
Year: 2019
Type: letter
Source: PubMed
Author: Yasemin Benderli Cihan
Institution: Kayseri Eğitim ve Araştırma Hastanesi
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2985590895
